Skip to main content

Optimal End Stage Renal Disease (ESRD) Starts

CBE ID
2594
1.5 Project
Endorsement Status
1.0 New or Maintenance
1.1 Measure Structure
Previous Endorsement Cycle
Is Under Review
No
Next Maintenance Cycle
Spring 2026
1.6 Measure Description

Information From 2015 Submission

Optimal End Stage Renal Disease (ESRD) Starts is the percentage of new adult ESRD patients during the measurement period who experience a planned start of renal replacement therapy by receiving a preemptive kidney transplant, by initiating home dialysis (peritoneal dialysis or home hemodialysis), or by initiating outpatient in-center hemodialysis via arteriovenous fistula or arteriovenous graft.

    Measure Specs
      General Information
      1.7 Measure Type
      1.3 Electronic Clinical Quality Measure (eCQM)
      1.14 Numerator

      The number of new ESRD patients age 18 and over who initiate outpatient renal replacement therapy in the twelve month measurement period with an optimal ESRD therapy (specific optimal ESRD therapies are defined in section S.6).

      1.15 Denominator

      The number of patients age 18 and over who receive a preemptive kidney transplant or initiate long-term dialysis therapy (do not recover kidney function by 90 days) for the first time in the twelve month measurement period

      Exclusions

      None

      Most Recent Endorsement Activity
      Endorsed Renal Spring 2022
      Initial Endorsement
      Last Updated
      Steward Organization
      The Permanente Federation
      Steward POC email
      Steward Organization Copyright

      N/A

                Public Comments